Bis(2´-C-methyladenosin-5´-yl) (11), bis(2´-C-methylguanosin-5´-yl) (13), bis(2´-Cmethyluridin-5´-yl) (15) and 2´-C-methylguanosin-5´-yl 2´-C-methyluridin-5´-yl (16) phosphodiesters have been prepared as pro-drug candidates for the respective 2´-Cmethylribonucleoside 5´-monophosphates, expectedly exhibiting antiviral activity against Hepatitis C virus. Additionally, the bis(2´-C-methyladenosine) diester has been converted to 3-acetyloxymethoxy-2,2-bis(ethoxycarbonyl)propyl (19) or pivaloyloxymethyl (20) triester. The underlying idea is that the 5´,5´-phosphodiester is first released by intracellular carboxyesterases and subsequently cleaved to nucleoside and nucleoside 5´-monophosphate by phosphodiesterases.
Introduction
Hepatitis C virus (HCV) infections constitute a worldwide health threat with an estimated 170 million infected individuals. 1, 2 Besides interferon based therapies, 3 inhibitors of the viral NS3-4A serine protease and the NS5B RNA polymerase have emerged as potential drug candidates. 4, 5 Among the RNA polymerase inhibitors, 2´-C-methylribonucleosides have received particular attention. 2´-C-methyl-3´-O-(L-valinyl)cytidine (Valopicitabine) 6, 7 and 4´-azido-3´,5´-di-O-(2-methylpropanoyl)cytidine 8 showed antiviral activity in phase II and phase I clinal trials, respectively, and 2´-C-methyladenosine and 2´-C-methylguanosine inhibited HCV RNA replication in vitro. 9 To terminate the synthesis of viral RNA, antiviral nucleoside analogues need to be converted to their 5´-triphosphates. Since conversion to the monophosphate often is the rate-limiting step, low antiviral activity may result from lack of this transformation by nucleoside kinases, and biodegradably protected nucleotides might, hence, be more potent drugs. 10 For example, 2´-C-methylguanosine has been reported to suffer from inefficient uptake and phosphorylation. 11 We now report on synthesis of novel type of pro-2´-Cmethylribonucleotides. Two 2´-C-methylribonucleosides are linked to each other via a 5´,5´-phosphodiester bond that additionally bears an esterase labile protecting group, either a pivaloyloxymethyl or 3-acetyloxymethoxy-2,2-bis(ethoxycarbonyl)propyl group. The underlying idea is that intracellular carboxyesterases first releases the 5´,5´-phosphodiester, which is then cleaved by phosphodiesterases to nucleoside and nucleoside 5´-monophosphate.
Results and Discussion
Conversion of 2´-C-methyladenosine, 2´-C-methylguanosine and 2´-C-methyluridine to a protected form allowing their 5´-phosphitylation and, hence, the assembly of their 5´,5´-phosphodiesters is outlined in Schemes 1-3, respectively. Accordingly, the 5´-OH of 2´-Omethyladenosine was first protected with a tert-butyldimethylsilyl group to give 1 and the 6-amino function then with a 4-methoxytrityl group (2; Scheme 1). Finally, the 2´-and 3´-OH groups were esterified with levulinic anhydride, prepared from levulinic acid in situ (3) , and the 5´-silyl protection was removed (4) . These two reactions deserve special attention. and the phosphite triester was oxidized to phosphate ester (12; Scheme 5). The levulinoyl and 2-cyanoethyl groups were removed with methanolic ammonia and the 4-methoxytrityl with aqueous acetic acid (13) . Finally, the ammonium counter ion was exchanged to sodium ion with the aid of a strong cation exchange resin. The same method was applied to preparation of bis(2´-C-methyluridin-5´-yl) phosphate (15; Scheme 6) from 2´,3´-di-O-benzoyl-2´-C-methyluridine (9) and preparation of 2´-Cmethylguanosin-5´-yl 2´-C-methyluridin-5´-yl phosphate (16; Scheme 7) from 9 and 3´-O-benzoyl-N 2 -(4-methoxytrityl)-2´-C-methylguanosine (6b). The low yields of compounds 11, 12 and 13 resulted from difficulties in chromatographic purification. The migration of the derivatives of 2´-C-methylguanosine, in particular, was accompanied by marked broadening of the bands Scheme 6. Reagents and conditions: (i) 1-chloro-1-(2-cyanoethoxy)-N,N-diisopropylphosphinamine, Et3N, DCM; (ii) 9, TetH, MeCN; (iii) I2, 2,6-lutidine, H2O, THF; (iv) NH3, MeOH; (v) Dowex 50WX8 Na + form, H2O Scheme 7. Reagents and conditions:
Two different esterase labile groups were used to protect the internucleosidic 5´,5´-phosphodiester linkage. 3-Acetyloxymethoxy-2,2-bis(ethoxycarbonyl)propyl group was introduced by phosphitylating the corresponding alcohol (17) 12 with bis[2´,3´-di-O-levulinoyl-N 6 -(4-methoxytrityl)-2´-C-methyladenosin-5´-yl-N,N-diisopropylphosphoramidite and oxidizing the phosphite triester obtained to a phosphate triester (18; Scheme 8). The levulinoyl protections were removed by hydrazinium acetate in methanol. The rather labile acetyloxymethoxy function of the phosphate protection group withstood this treatment. The deprotected triester (19) was obtained by removal of the 4-methoxytrityl group with 80% aq acetic acid. Introduction of the commonly used pivaloyloxymethyl group turned out to be difficult. Reaction of bis[2´,3´-di-O-levulinoyl-N 6 -(4-methoxytrityl)-2´-C-methyladenosin-5´-yl] phosphate with chloromethyl pivalate was attempted in many solvents. The best result was obtained in N-methylpyrrolidone. The overall yield after removal of the levulinoyl and 4-methoxytrityl protections was, however, only 15% (20; Scheme 9). The antiviral activity of the compounds will be tested by AliosBiopharma.
Experimental Section
General. Chemicals were purchased from Sigma-Aldrich, Fluka, Merck and Ramidus. MeCN, DCM, THF and pyridine were dried over 4Å molecular sieves and 1,4-dioxane over 3Å molecular sieves. Et3N was dried by refluxing over CaH2, distilled before use and stored over CaH2 lumps. Reactions were monitored with TLC (Merck silica gel 60 F254 aluminium sheets) or with 31 P-NMR. Column chromatography was performed on silica gel (Fluka silica gel 60 230-400 mesh).
1 H-, 13 C-, 31 P-and 2D-NMR spectra were recorded on Bruker Avance 400 or 500 spectrometer at 25ºC. The chemical shifts are given in ppm with reference to internal TMS, the coupling constants J are given in Hz. High resolution mass spectra were recorded on Bruker Daltonics microTOF-Q using electrospray ionization.
5´-O-(tert-Butyldimethylsilyl)-2´-C-methyladenosine (1)
. 2´-C-Methyladenosine 1 (5.26 mmol; 1.48 g) was coevaporated twice from dry pyridine and dissolved in the same solvent (10 mL). tert-Butyldimethylsilyl chloride (5.21 mmol; 0.81 g) was added and the reaction mixture was stirred for 18 h at r.t. Volatiles were removed and the residue was dissolved in DCM, washed with saturated aqueous NaHCO3 and brine, dried over Na2SO4, and evaporated to dryness. The crude product was purified on a silica gel column eluting with 5% MeOH in DCM. 
5´-O-(tert-Butyldimethylsilyl)-2´,3´-di-O-levulinoyl-N
6 -(4-methoxytrityl)-2´-C-methyladenosine (3). Levulinic acid (16.36 mmol; 1.90 g) was dissolved in dry 1,4-dioxane (20 mL) and cooled on an ice bath. Dicyclohexylcarbodiimide (DCC; 8.58 mmol; 1.77 g) was added portion wise within an hour. The reaction mixture was filtered and the precipitate was washed with dry 1,4-dioxane (10 mL). Compound 2 (3.16 mmol; 2.11 g) was coevaporated with dry pyridine and dissolved in the same solvent (10 mL) and the levulinic anhydride in 1,4-dioxane was added together with a catalytic amount of 4-dimethylaminopyridine (DMAP). The reaction mixture was stirred at r.t. overnight, heated on an oil bath at 54 °C for 5 hours and stirred again over night at r.t. The reaction mixture was evaporated to dryness, the residue was dissolved in DCM and washed with H2O, saturated aqueous NaHCO3 and brine. The crude product, dried over Na2SO4, was purified twice by silica gel chromatography, first eluting with 2% MeOH in DCM and then with 1% MeOH in DCM. According to the NMR spectrum, a mixture of products containing one or two levulinoyl groups was obtained, the singly acylated product predominating. The mixture of products was subjected to another levulinoylation. Levulinic acid (11.19 mmol; 1.30 g) was dissolved in dry DCM (20 mL) and DCC (5.48 mmol; 1.13 g) was added in one portion. The reaction mixture was stirred at r.t. overnight and filtered. The precipitate was washed with dry DCM (5 mL) and the DCM phases were combined. The filtrate and a catalytic amount of DMAP were added to the mixture (2.11 g) in dry DCM (5 mL). Owing to sluggish progress of the reaction, dry Et3N (0.50 mL) and some DMAP were after one day added to the reaction mixture. The reaction was completed in 4 days. The reaction mixture was washed with H2O, saturated aqueous NaHCO3 and brine, dried over Na2SO4, and evaporated to dryness. The crude product was purified on a silica gel column eluting with 1% MeOH in DCM. Compound 3 was obtained as yellowish solid in 72% yield (1.98 g). 
5´-O-(tert-Butyldimethylsilyl)-N 2 -(4-methoxytrityl)-2´-C-methylguanosine (5)
. 2´-C-Methylguanosine (12.28 mmol; 3.65 g) was dried over P2O5 for two days, dissolved in dry pyridine (30 mL) and tert-butyldimethylsilyl chloride (12.27 mmol; 1.85 g) was added. The reaction mixture was stirred at r.t. for 24 hours and evaporated to dryness. The residue was coevaporated three times with dry pyridine and dissolved in the same solvent (15 mL). 4-Methoxytrityl chloride (12.27 mmol; 3.79 g) was added and the reaction mixture was heated on an oil bath at 57 °C for 20 hours and evaporated to dryness. The residue was dissolved in DCM, washed with saturated aqueous NaHCO3 and brine, dried over Na2SO4, and evaporated to dryness. The crude product was purified three times on a silica gel column: first with 8% MeOH in DCM, then with 4% MeOH in DCM and finally by using gradient elution from 1% to 4% MeOH in DCM. Compound 5 was obtained as white solid in 82% yield (6.88 g Levulinic acid (4.82 mmol; 0.56 g) was dissolved in dry DCM (20 mL), DCC (2.90 mmol; 0.60 g) was added and the reaction mixture was stirred at r.t. for 4 hours. Precipitated dicyclohexylurea was removed by filtration and compound 5 (1.94 mmol; 1.33 g) in DCM (2 mL) and a catalytic amount of DMAP and Et3N (0.80 ml) were added. The reaction mixture was stirred at r.t. over night. The mixture was washed with H2O and brine. The organic layer was dried over Na2SO4 and evaporated to dryness. The crude product was purified on a silica gel column eluting with 1 to 3% MeOH in DCM. According to NMR spectroscopy, the main product bore only one levulinoyl group. The product was used as such for the next step. Accordingly, the levulinoylated nucleoside was dissolved in a mixture of dry THF (20 mL) and acetic acid (4 mL). Tetrabutylammonium fluoride hydrate (2.95 mmol, 0.77 g) was coevaporated from dry THF and added to the reaction mixture in the same solvent (1 mL). The mixture was evaporated to dryness after 21 hours stirring at r.t. The residue was equilibrated between EtOAc and saturated aqueous NaHCO3. The organic layer was washed with brine, dried over Na2SO4, and evaporated to dryness. The crude product was purified on a silica gel column eluting with 5% MeOH in DCM. The product was obtained as white solid in 50% yield (0.64 g 
-(4-Methoxytrityl)-3´-O-benzoyl-2´-C-methylguanosine (6b).
Compound 5 (1.74 mmol; 1.19 g) was coevaporated three times with dry pyridine and the residue was dissolved in the same solvent (5.0 mL). The solution was cooled on an ice bath and benzoyl chloride (4.39 mmol; 0.22 mL) was added. The solution was stirred at r.t. overnight and evaporated to dryness. The residue was dissolved in DCM (5.0 mL) and washed with brine. The organic phase was dried over Na2SO4 and evaporated to dryness. The crude product was isolated by Silica gel chromatography eluting with DCM containing MeOH from 5% to 8% MeOH. HR-ESI-MS: [M+H] + obsd. 788.3393, calcd. 788.3474. According to 1 H-and 13 C-NMR spectroscopic characterization, the desired product, 5´-O-(tert-butyldimethylsilyl)-N 2 -(4-methoxytrityl)-3´-Obenzoyl-2´-C-methylguanosine, was contaminated with some impurities. In spite of this, the crude product was subjected as such to desilylation that was carried out as described above for compound 6a. The crude product was purified by silica gel chromatography eluting with DCM that contained 5% MeOH. Compound 6b was obtained as white solid in 53% yield (0.52 g). 1 
5´-O-(4-Methoxytrityl)-2´-C-methyluridine (7)
. 2´-C-Methyluridine (0.79 g; 3.05 mmol) was dissolved in dry pyridine (20 mL) under argon. 4-Methoxytrityl chloride (1.03 g; 3.36 mmol) was added and the mixture was stirred at 50 °C for 20 hours. The reaction was quenched with saturated aq NaHCO3 (50 mL) and subjected to DCM (3 × 100 mL) workup. The organic phase was dried over Na2SO4 and evaporated to dryness. The residue was purified by Silica gel chromatography using DCM containing 5% MeOH as eluent. 
2´,3´-di-O-Benzoyl-5´-O-(4-methoxytrityl)-2´-C-methyluridine (8). 5´-O-(4-Methoxytrityl)-2´-
C-methyluridine (1.50 g; 2.87 mmol) (7) was dissolved in dry pyridine (60 mL). Benzoyl chloride (0.83 mL, 7.17 mmol) was added and the mixture was stirred overnight at room temperature. The reaction was quenched with cold water and the mixture was evaporated to dryness. The residue was dissolved in DCM and washed with water (3 × 100 mL). The organic phase was dried over Na2SO4 and evaporated to dryness. The residue was purified by Silica gel chromatography using DCM containing 10% EtOAc as eluent. Compound 8 was obtained as solid in 77% yield (1.63 g). 
2´,3´-Di-O-benzoyl-2´-C-methyluridine (9)
. 2´,3´-Di-O-benzoyl-5´-O-(4-methoxytrityl)-2´-Cmethyluridine (1.88g; 2.54 mmol) (8) was dissolved in 80% (v/v) aq AcOH (36 mL). After stirring overnight at room temperature, the mixture was evaporated to dryness. The residue was dissolved in dichloromethane (100 mL) and washed with water (2 × 100 mL). Organic phase was dried over Na2SO4 and evaporated to dryness. The residue was purified by Silica gel chromatography eluting with a 7:3 mixture of DCM and EtOAc. 
Bis[2´,3´-di-O-levulinoyl-N
6 -(4-methoxytrityl)-2'-C-methyladenosin-5´-yl] phosphate (10). Compound 4 (1.82 mmol; 1.37 g) was dried on P2O5 over two nights and dissolved in dry DCM (6 mL) under nitrogen. Dry Et3N (9.28 mmol; 1.29 mL) and 1,1-dichloro-N,Ndiisopropylphosphinamine (0.97 mmol; 180 µL) were added and the reaction mixture was stirred at r.t. for 1,5 hours. To complete the reaction, another portion of 1,1-dichloro-N,Ndiisopropylphosphinamine (0.27 mmol; 50 µL) was added and the mixture was stirred for 30 minutes. The reaction mixture was then passed through a short silica gel column eluting with EtOAc/hexane (8:2, v/v) containing 0.5% Et 3 N. The solvents were removed under reduced pressure and the residue was co-evaporated two times from dry MeCN.
31 P-NMR signal at 149.66 ppm verified the formation of the desired dinucleoside phosphoramidite. The product (0.44 mmol; 0.72 g) was dissolved in MeCN (1 mL), and 1-H-tetrazole (5.22 mmol; 11.60 mL of 0.45 mol L -1 solution in MeCN) and H2O (8.00 mL) were added. The progress of the reaction was followed by 31 P-NMR spectroscopy. After 75 min, 7 mL of 0.15 mol L -1 solution of I2 (1.05 mmol) in a 4:2:1 mixture of THF, H2O and 1,2-lutidine was added. The oxidation was completed in 2.5 hours. The product was isolated by conventional 5% aq NaHSO3/DCM workup. The crude product was purified on a silica gel column with gradient elution from 5% to 10% MeOH in DCM. Compound 10 was obtained as yellowish solid in 70% yield (0.39 g). 
Bis(2´-C-methyladenosin-5´-yl) phosphate (11).
Compound 10 (0.04 mmol; 0.06 g) was dissolved in DCM (0.50 mL) and hydrazinium acetate (0.32 mmol; 0.03 g) in MeOH (0.2 mL) was added. After 20 hours stirring at r.t., the reaction mixture was evaporated to dryness and the residue was dissolved in 80% aqueous AcOH (1 mL) and stirred at r. 
2-Cyanoethyl bis[3´-O-levulinoyl-N
6 -(4-methoxytrityl)-2´-C-methylguanosin-5´-yl] phosphate (12). Compound 6a (0.48 mmol; 0.32 g) dried over P 2 O 5 over night was dissolved in dry DCM (3 mL) under N2. Dry Et3N (2.41 mmol; 335 µL) and 1-chloro-1-(2-cyanoethoxy)-N,Ndiisopropylphosphinamine (0.53 mmol; 118 µL) were added. After 1 hour stirring at r.t., the mixture was passed through a short silica gel column eluting with EtOAc that contained 0.5% Et 3 N. The solvents were removed under reduced pressure and the residue was co-evaporated from dry MeCN. The residue was dissolved in dry MeCN (2 mL) and compound 6 (0.48 mmol; 0.32 g) and 1-H-tetrazole (0.96 mmol; 2.13 mL of 0.45 mol L -1 solution in MeCN) were added under N2, and the mixture was stirred for 1.5 hours. The phosphite ester obtained was oxidized as described above for compound 10. The phosphate triester 12 was isolated by conventional 5% aq NaHSO3/DCM workup. The crude product was purified on a silica gel column eluting with 5 to 10% MeOH in DCM. Bis(2´-C-methylguanosin-5´-yl) phosphate (13). Compound 12 (0.10 mmol; 0.15 g) was dissolved in 30% methanolic ammonia (25 mL) and the mixture was stirred at r.t. overnight, and evaporated to dryness under reduced pressure. The residue was dissolved in 80% aq AcOH (10 mL) and the mixture was stirred at r.t. for 3 days. The crude product obtained by evaporation to dryness was equilibrated between H2O and hexane. The aqueous phase was evaporated to dryness and the product was purified by HPLC as described above for compound 11. The product was dissolved in water and passed through an ion-exchange column (Dowex Na + -form, 50Wx8, 100-200 mesh) and evaporated to dryness. Cyanoethyl bis(2´,3´-di-O-benzoyl-2´-C-methyluridin-5´-yl) phosphate (14) . 2´,3´-Di-Obenzoyl-2´-C-methyluridine (0.225 g; 0.48 mmol) (9) dried over P2O5 overnight was dissolved in dry DCM (5 mL) under argon. Anhydrous triethylamine (0.336 mL; 2.41 mmol) and 1-chloro-1-(2-cyanoethoxy)-N.N-diisopropylphosphinamine (0.118 mL; 0.53 mmol) were added. The mixture was stirred at room temperature for 1 hour. The product was isolated by passing the mixture through a short silica gel column with dry EtOAc containing 0.5% Et 3 N. The solvent was removed under reduced pressure and the product was coevaporated twice with dry acetonitrile (2 × 20 mL) to remove the traces of Et3N. The phosphitylated nucleoside was dissolved in dry MeCN (1 mL) under argon. Nucleoside 9 (0.225 g; 0.48 mmol, dried over P2O5 overnight) in dry MeCN (2 mL) and tetrazole (1.92 mmol, 4.2 mL of 0.45 mol L -1 solution in MeCN) were added. The mixture was stirred for 2 hours. The phosphite ester formed was oxidized with I2 as described above form compound 10 and subjected to 5% aq NaHSO3/DCM workup. The product was purified by Silica gel chromatography, eluting with DCM containing 5% MeOH. Compound 14 was obtained as solid in 52% yield (0.26 g). , CH2CN 
Bis(2´-C-methyluridin-5´-yl) phosphate (15).
Compound 14 (130mg; 0.124 mmol) was dissolved in mathanolic ammonia (2.0 mL; 7 mol L -1 ) on an ice bath. After stirring overnight (20 h) at room temperatue, the mixture was evaporated to dryness. The product was purified by RP-HPLC on a Lichrochart ® Prep C18 column (250 x 10 mm, 5 μm, flow rate 3.0 mL min -1 ) eluting with water that contained 3% MeCN. Compound 15 was obtained as an ammonium salt in 87% yield (62 mg). Finally, the product was converted to sodium salt as described above for compound 13. pivalate (POMCl, 25 µL, 0.18 mmol) was added and the reaction was allowed to proceed at 60 °C for 3 days. One equivalent of Et3N (13 µL, 0.09 mmol) and POMCl (13 µL, 0.09 mmol) was added and the reaction mixture was stirred for one more day. The mixture was equilibrated between water and EtOAc. The organic layer was washed with brine and evaporated to dryness. The residue was filtered through a short silica gel column eluting with 5% MeOH in DCM. The crude product was dissolved in DCM (600 µL) and hydrazinium acetate (0.044 g, 0.48 mmol) in MeOH (200 µL) was added. The reaction mixture was stirred at r.t. for 18 hours. The unreacted hydrazinium acetate was destroyed with acetone and the reaction mixture was evaporated to dryness. The residue was dissolved in 80% aqueous acetic acid (1 mL) and the mixture was stirred at r.t. for 24 hours. The crude product was purified by HPLC as described above for compound 11. Compound 20 was obtained as white solid in 15% yield (10 mg 
